KELLY SMITH: Open Payments
NPI 1780673772 · MOUNDSVILLE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 33 payments from 12 companies in 2025. Trend: 2023 $886 · 2024 $856 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $163 |
| Novo Nordisk Inc | 7 | $107 |
| ABBVIE INC. | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| PFIZER INC. | 3 | $48 |
| Lilly USA, LLC | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Averitas Pharma Inc. | 1 | $36 |
| Alkermes, Inc. | 1 | $25 |
| Blueprint Medicines Corporation | 1 | $24 |
Products named: FARXIGA, VRAYLAR, TRELEGY ELLIPTA, Wegovy, MOUNJARO, CAPLYTA, QUTENZA, NURTEC ODT.
Industry payments across WV — which companies pay providers there.
